December 07, 2020 BY CYNTHIA DEMARCO
Most cancer patients and their caregivers
will hear the word “immunocompromised” at some point.
But what does that actually mean? What
causes someone to be immunocompromised? And why is it important to know if you
are or not, especially during the coronavirus
(COVID-19) pandemic?
We spoke with pulmonologist Scott Evans, M.D. Here’s what he had
to say.
What does it mean to be
immunocompromised?
The term “immunocompromised” is actually
quite broad and relatively poorly defined. But generally speaking, it means
someone’s immune system isn’t working as well as it should be to protect them
against infections.
Being immunocompromised can lead both to
worse illness from common infections and to increased susceptibility to
uncommon infections, such as a Pneumocystis
jirovecii.
What causes someone to
become immunocompromised?
People can become immunocompromised for many
reasons, including advanced age, metabolic disorders (such as diabetes), cancer treatments, and even cancer itself.
In cancer patients, being immunocompromised
usually relates to the impairment of white blood cells, whether in number or
function. Cancer often develops because the immune system fails to identify and
eliminate abnormal cells. And in patients with blood cancers such as leukemia, lymphoma or multiple
myeloma,
the immune system may not function properly even if the person has a normal
number of white blood cells.
Cancer patients who are preparing for
a stem
cell transplant are
among the most vulnerable, as chemotherapy is intentionally
used to reduce their immune function and then recover it with the transplant.
Are there different
degrees of immunocompromization? Is there any type of scale that people can use
to determine their own relative risk?
There’s really no universal standard scale
for quantifying how immunocompromised someone is. But a particular type of
white blood cell called a neutrophil can be one indicator of risk. This
relationship was actually discovered
here at MD Anderson back in the mid-1960s, and it was an incredibly
important finding.
Gerald Bodey, M.D., and his colleagues
showed that when neutrophil levels drop below 1,000 cells per microliter,
patients’ susceptibility to infection goes up significantly. And if their
levels drop under 500, patients’ risk goes up even higher. Low neutrophil
counts are referred to as neutropenia.
The risk of contracting unusual infections
goes up significantly in patients with AIDS, too, when their helper T-cell
counts fall below 500.
Is there anything that can
be done to treat immunocompromization clinically?
There are therapies we can give people to
stimulate production of white blood cells called granulocytes, which includes
neutrophils. We can also give people infusions of donated lymphocytes, another
type of white blood cell.
But our main focus is treating the cancer,
so that patients’ own immune function can be restored.
What challenges do
immunocompromised patients face, and how can these be managed?
Many severely immunocompromised patients
were already wearing
masks prior
to COVID-19, but outside the pandemic, many less-compromised patients don’t
normally need to. They just have to engage in reasonable behaviors, such as
avoiding sick people. Depending on the nature of a person’s particular immune
dysfunction, certain hobbies, like gardening and spelunking, might put them at
greater risk due to fungal exposure.
That being said, there is a huge discrepancy
in immune function between individuals. So, it’s really best to talk to your
own care team about your status and relative risk. Someone who has diabetes or
cirrhosis of the liver is going to be at higher risk than the general
population, but it’s still not going to be the same as someone who has just
received a stem cell transplant. And different populations will have different
germs that they’re susceptible to.
Some chemotherapies can have long-lasting
effects on an immunocompromised patient’s system. Even 18 or 24 months after
taking certain chemotherapy drugs, they can still see lingering side
effects.
So it’s important to talk to your care team about how long you should still
take precautions, and which ones to continue even after treatment ends.
Request an appointment
at MD Anderson online or by calling 1-855-970-1235.
Topics
LymphomaStem Cell Transplantation Cellular
TherapyMultiple MyelomaChemotherapyLeukemiaCOVID-19
No comments:
Post a Comment